News & Press Release
2012
- All Categories
- Announcements
- HR and Organization
- Product Information
-
- 2012-11-14 Product Information NHI price listing for NPC-08 (Antineoplastic Agent Gliadel 7.7mg for Implant)
- 2012-10-31 Product Information Apply for marketing approval of NPC-05 （Talc）
- 2012-09-30 Announcements Shiomura, CEO gave a lecture at National Institute of Biomedical Innovation
- 2012-09-29 Product Information Approval received for Manufacturing and Marketing of NPC-08 (Antineoplastic Agent Gliadel 7.7mg for Implant)
- 2012-09-01 Product Information NPC-12 (Sirolimus) has been specified for orphan drug
- 2012-08-01 Announcements Shiomura, CEO gave a lecture at Parent Association of Alternating hemiplegia of childhood
- 2012-07-07 HR and Organization Plenary meeting of Sales & Marketing held for two days
- 2012-07-06 Product Information Submitted application for approval of Manufacturing and Marketing Authorization of NPC-07（aminolevulinic acid）
- 2012-06-03 Product Information Completion of clinical experience investigation for neonatal seizure for Nobelbar 250mg for Injection
- 2012-06-02 Product Information Submitted application for approval of Manufacturing and Marketing Authorization of NPC-01 (Ultra low dose hormones preparation)
- 2012-06-01 Announcements Licensing Agreement on Sirolimus for Japan was concluded with Pfizer
- 2012-05-01 Announcements Medical Information eXpress, interview with Shiomura, CEO on PRESIDENT column, May 2012
- 2012-04-08 Announcements Shiomura, CEO gave a lecture at Patients Association for Distal Myopathies Symposium
- 2012-03-01 HR and Organization The 9th Ordinary General Meeting of Shareholders
- 2012-02-05 Announcements President Shiomura spoke at the symposium of the 7th International Conference of Rare Disease(ICORD).
- 1
- 2